Stocks · Korea 373110 KOSDAQ

Xcell Therapeutics

1,035원 -2.82% Market cap 179억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR2.51x
EPS0 KRW
BPS413 KRW
ROE-172.83%
DPS0 KRW

Returns and 52-week range

1W+3.71%
1M-7.59%
3M-12.36%
6M-27.97%
1Y-64.14%
YTD-39.90%
52W high3,455원
52W low951원
From 52W high-70.04%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
202311억-87억-93억-774.6%
202419억-93억-95억-482.3%
202519억-109억-109억-556.8%
Quarterly
2024 4Q5억-25억-24억-524.5%
2025 1Q3억-26억-26억-775.8%
2025 2Q2억-27억-27억-1,203.2%
2025 3Q3억-24억-23억-709.9%
2025 4Q11억-33억-34억-306.2%
2026 1Q10억-29억-29억-285.2%

Company

CEO이의일
Founded2015-09-14
Fiscal year end12
Address: 서울특별시 강남구 영동대로 333 동원빌딩 6층

Peers in the same sector

CompanyMarket capP/EP/B1M
엠에프씨224억25.340.70+4.61%
피씨엘168억—2.52+0.00%
풍전약품225억77.830.57-7.34%
피플바이오136억—0.43+0.00%
서울제약225억29.750.55-1.07%
올리패스134억—7.94+0.00%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Recent news

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.